Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial) - Takeaways - MDSpire

Colorectal neoplastic emergencies in immunocompromised patients: preliminary result from the Web-based International Register of Emergency Surgery and Trauma (WIRES-T trial)

  • By

  • Federico Coccolini

  • Alessio Mazzoni

  • Camilla Cremonini

  • Luigi Cobuccio

  • Marsia Pucciarelli

  • Guglielmo Vetere

  • Beatrice Borelli

  • Silvia Strambi

  • Serena Musetti

  • Mario Miccoli

  • Chiara Cremolini

  • Dario Tartaglia

  • Massimo Chiarugi

  • May 9, 2023

  • 0 min

Share

  • 1

    The study analyzed 839 patients with colorectal neoplastic emergencies associated with immunocompromised states.

  • 2

    Patients were categorized into mild-moderate and severe immunocompromised groups, with 80.7% classified as mild-moderate.

  • 3

    The median age of patients was 71.9 years for mild-moderate and 73 years for severe immunocompromised groups.

  • 4

    Mortality rates were 5.1% in the mild-moderate group and 12.8% in the severe group, with ASA score influencing outcomes.

  • 5

    The sigmoid colon was the most common site for colorectal neoplastic emergencies, occurring in 40% of mild-moderate cases.

Original Source(s)

Related Content